Home » Topics » Disease categories and therapies » Infection

Infection
RSS

FK-463, Fujisawa's antifungal agent, in late-stage clinical trials in U.S.

Dec. 28, 1999

DJ Pharma to market Schering-Plough antibiotic in U.S.

Dec. 28, 1999

New beta-lactams with activity against resistant staphylococci

Dec. 27, 1999

Compounds active against RNA viruses emerge from research at Italian university

Dec. 23, 1999

New oral carbapenems with activity against wide range of bacteria

Dec. 23, 1999

Chinese investigators describe antimycoplasmal activity of new quinolone

Dec. 23, 1999

FDA is first agency worldwide to approve new fluoroquinolone for marketing

Dec. 22, 1999

Neose Technologies discontinues development of NE-1530

Dec. 21, 1999

Banyu isolates novel antifungal substance BE-54753

Dec. 21, 1999

FDA approves topical treatment for nail fungus

Dec. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...